For citations:
PANCHENKO E.P. HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? Aterotromboz = Atherothrombosis. 2017;(2):32-42. (In Russ.) https://doi.org/10.21518/2307-1109-2017-2-32-42
This work is licensed under a Creative Commons Attribution Attribution-NonCommercial-NoDerivs License.
Email this article 